SMS Pharmaceuticals’ strong Q2 results

SMS Pharmaceuticals Gains After USFDA Approval of Reformulated Ranitidine Tablets | Q2 Numbers Show Strong Growth

The mood around SMS Pharmaceuticals shifted quickly this week. A familiar drug—once at the centre of global safety conversations—made its way back to the US market. And this return came with a direct connection to SMS Pharma’s partner, VKT Pharma, earning USFDA approval for its reformulated Ranit...